The elimination of a foreign antigen is a function of the antibody, complement and phagocyte systems. When an immune complex is formed in the circulation, clearance is effected by cells of the reticuloendothelial system. Macrophages and polymorphonuclear cells have both IgG Fc and C3b complement receptors so that opsonisation by either the classical or the alternative pathway of complement activation facilitates antigen elimination. This system normally provides a most efficient protection against disease, since man is continually challenged by a variety of inhaled and ingested antigens.
Why then does a normally protective system become self-damaging, resulting in immune complex disease? It is unlikely that most immune complex diseases are due to rare or as yet unidentified antigens. It is much more likely that host variation in immune response to a common antigen resuits in effective clearance and health in one individual, but persistent circulating antigen and immune complex disease in another. Increased concentrations of circulating soluble immune complexes are found in a variety of diseases; these include systemic lupus erythematosus, various forms of glomerulonephritis, rheumatoid arthritis, and chronic inflammatory bowel diseases. ' High concentrations of immune complexes are also found in many forms of disseminated malignancy2 where it is thought that they may have an enhancing effect on tumour growth, by preventing the host from mounting an effective immune response to his own tumour. 3 Paradoxically, immune complexes are also found, in low concentrations, in the sera of apparently healthy people, particularly after food;4 they have also been described in normal pregnancy,5 and in pre-eclampsia. 6 The finding of immune complexes in so many different diseases as well as in normal biological states raises the question whether they do indeed play a crucial role in pathological processes.
Evidencefor a damaging role ofimmune complexes Much of the evidence comes from animal studies, in particular those in which chronic nephritis is induced by repeated antigen administration.7 The most widely quoted experimental model of immune complex injury is serum sickness, in which the animal develops nephritis and vasculitis due to deposition of immune complexes [8] [9] [10] days after the injection of antigen. When the antigen is still in excess of antibody within the circulation, the small immune complexes formed remain in solution but can become trapped in vessel walls at sites of turbulence or at capillary membranes where filtration occurs. Tissue damage at these sites results from the biological effects of complexes which activate the complement system, resulting in immune adherence, polymorph chemotaxis, release of lysosomal proteolytic enzymes and kinins, and platelet aggregation. The latter causes release of vasoactive amines8 which increase vascular permeability and so further localise complexes to the site of the injury.
If sections of the kidneys are examined at the height of injury, the glomeruli show evidence of nephritis, with endothelial cell swelling and lifting of the underlying basement membrane. Immuno '3 demonstrated that only certain strains of mice were susceptible to chronic nephritis when infected with lymphocytic choriomeningitis virus in the neonatal period. In response to antigen injected in saline, the strains of mice susceptible to chronic nephritis produced lower-affinity antibody-that is, with weaker antigen-antibody binding than the nephritisresistant animals,'4 suggesting that susceptibility was genetically determined. Low affinity antibody is poor at antigen elimination '5 and is one example of a defective rather than an overactive immune system failing to eliminate antigen and so predisposing to chronic immune complex disease. There are many examples in man of immune complex disease with underlying primary immune deficiency-for example, the higher incidence of juvenile chronic polyarthritis in children with selective IgA deficiency,'6 the arthritis complicating hypogammaglobulinaemia, '7 and the increased incidence of diseases such as systemic lupus erythematosus in people with inherited deficiencies of the complement system, in particular homozygous C2 deficiency. '8 The genetic differences in susceptibility to immune complex disease in animals is antigen non-specific. It is likely that this is true also for man since a common antigen such as hepatitis B can occur in the healthy carrier state, yet has been incriminated in such different diseases as chronic active hepatitis, '9 antibody to activated C3bi. Another factor is the action of complement in solubilising membranebound immune complexes. 25 Thus immune complexes vary not only in the antigen but also in the immunoglobulin class and subclass, in size, in complement-binding capacity and in the antigen:antibody ratio (Fig. 1 ). All these features may be important in the localisation of complexes in one organ rather than another, and in the different syndromes and diseases which result. (Table   2) .
With the exception of the electron microscope, by which it is occasionally possible to identify the specific antigen, all the other techniques are antigen non-specific. The antiantibody method, which Table 3 gives the results of 10 commonly sed assays applied to the same SLE sera; it is readily apparent that in this disease some assays give a higher percentage of positives than others with the Raji cell assay ranking highest, due in part to false-positive reactions with antilymphocyte antibodies. However by understanding the specificities of the different assays and applying several with different probes to the same serum, some degree of characterisation can be achieved. Since immune complexes are clearly heterogeneous and only some are of pathological significance, it is important to apply this type of finger-printing exercise in order to assess whether the immune complexes play any role in a particular disease. Table 4 indicates how the size Table 5 illustrates certain aspects of this "fingerprinting" exercise for renal diseases in which immune complexes may play a role. (Fig. 3) , though in others, such as steroid-responsive nephrotic syndrome and HSP nephritis, no such correlation is obtained (Fig. 4) . 
